Affordable Access

How much do the public sector and the private sector contribute to biopharmaceutical R&D?

Authors
  • Simoens, Steven; 43289;
  • Huys, Isabelle; 31958;
Publication Date
Apr 01, 2022
Source
Lirias
Keywords
License
Unknown
External links

Abstract

When examining the prices of new medicines, the question of how much the private and public sectors have contributed to their R&D is often raised. Contributions can be assessed in terms of the investment, authorship of publications, marketing authorizations and intellectual property rights associated with biopharmaceutical R&D. This review of the empirical evidence underlines the complementary and interwoven nature of the private and public sectors in supporting biopharmaceutical R&D. Both sectors invest in and contribute to biopharmaceutical R&D, with the public sector predominantly focusing on basic research and the private sector mainly targeting medicine discovery and development. Public-sector investment generates additional private-sector investment. / status: published

Report this publication

Statistics

Seen <100 times